Trial intelligence / Profile preview

Memantine for tension-type headache

IRCT2017081635710N2Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Sep 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of memantine in tension-type headache (TTH), sponsored by Shiraz University of Medical Sciences. Started Sep 2017; status: completed.

02

Drugs

memantine
03

Conditions

tension-type headache (TTH)

Beyond the preview

Go deeper on IRCT2017081635710N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT2017081635710N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call